{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:08Z","timestamp":1788912008007,"version":"build-2803163510"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2025.145283","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145283","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:15:23Z","timestamp":1750076123000},"page":"145283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["RETRACTED: A novel PEGylated squid-derived protamine protein in combination with sorafenib effectively inhibits hepatocellular carcinoma growth"],"prefix":"10.1016","volume":"319","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeevithan","family":"Elango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145283_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0015","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/cancers15225378","article-title":"Current trends in surgical management of hepatocellular carcinoma","volume":"15","author":"Angeli-Pahim","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43066-023-00306-3","article-title":"Latest advances in hepatocellular carcinoma management and prevention through advanced technologies","volume":"14","author":"Addissouky","year":"2024","journal-title":"Egypt. Liver J."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-642-54490-3_8","article-title":"Sorafenib: targeting multiple tyrosine kinases in cancer","volume":"201","author":"Hasskarl","year":"2014","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102434","article-title":"Mechanisms of sorafenib resistance in hepatocellular carcinoma","volume":"48","author":"Liang","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0045","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41401-020-0395-5","article-title":"Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells","volume":"41","author":"Yao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2018.05.027","article-title":"Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3\/ERK\/AKT","volume":"832","author":"Mao","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155317","article-title":"Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells","volume":"128","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111091","article-title":"Marine-derived drugs: recent advances in cancer therapy and immune signaling","volume":"134","author":"Saeed","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134307","article-title":"Enzymatic response of heparin-protamine complex: spectroscopic investigation and application for lung adenocarcinoma cells detection","volume":"277","author":"Qi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/md22060255","article-title":"Stem-cell-regenerative and protective effects of squid (Symplectoteuthis oualaniensis) skin collagen peptides against H2O2-induced fibroblast injury","volume":"22","author":"Wei","year":"2024","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0075","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jtha.2023.04.005","article-title":"What\u2019s fishy about protamine? Clinical use, adverse reactions, and potential alternatives","volume":"21","author":"Levy","year":"2023","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0080","article-title":"\u201cRich arginine and strong positive charge\u201d antimicrobial protein protamine: from its action on cell membranes to inhibition of bacterial vital functions","volume":"2024","author":"Ookubo","year":"1866","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/ijms26051869","article-title":"Polyethylene glycolylation of the purified basic protein (protamine) of squid (Symplectoteuthis oualaniensis): structural changes and evaluation of proliferative effects on fibroblast","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2017.10.055","article-title":"Self-assembled nanocomplex of PEGylated protamine and heparin\u2013suramin conjugate for accumulation at the tumor site","volume":"535","author":"Park","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12079-018-0492-0","article-title":"Protein PEGylation for cancer therapy: bench to bedside","volume":"13","author":"Gupta","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0100","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","article-title":"Molecular mechanisms of apoptosis and roles in cancer development and treatment","volume":"16","author":"Goldar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0105","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1590\/1519-6984.228437","article-title":"Apoptosis (programmed cell death) and its signals - a review","volume":"81","author":"Obeng","year":"2021","journal-title":"Braz. J. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0110","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0115","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd3216","article-title":"Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements","volume":"9","author":"Kummar","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963317","article-title":"Synergistic effects of natural products in combination with anticancer agents in prostate cancer: a scoping review","volume":"13","author":"Cheon","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fntpr.2023.1309994","article-title":"Natural product based anticancer drug combination discovery assisted by deep learning and network analysis","volume":"2","author":"Cao","year":"2024","journal-title":"Front. Nat. Prod."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40880-019-0412-6","article-title":"Targeting mitochondria as an anticancer strategy","volume":"39","author":"Dong","year":"2019","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0150","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.3390\/ijms21217941","article-title":"Mitocans revisited: mitochondrial targeting as efficient anti-cancer therapy","volume":"21","author":"Dong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111329","article-title":"Mitochondrial signaling pathways and their role in cancer drug resistance","volume":"122","author":"Sharma","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0160","series-title":"Encyclopedia of Cancer","first-page":"2333","article-title":"Mitochondrial membrane permeabilization in apoptosis","author":"Brenner","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0165","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","article-title":"Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions","volume":"30","author":"Bernardi","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116663","article-title":"H2AX: a key player in DNA damage response and a promising target for cancer therapy","volume":"175","author":"Prabhu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0175","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0180","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1038\/cddis.2016.138","article-title":"Erianin induces G2\/M-phase arrest, apoptosis, and autophagy via the ROS\/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0185","doi-asserted-by":"crossref","first-page":"10845","DOI":"10.1038\/s41598-023-38021-z","article-title":"P53 status, and G2\/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma","volume":"13","author":"Mehdizadeh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10495-011-0660-7","article-title":"Inhibition of checkpoint kinase 1 abrogates G2\/M checkpoint activation and promotes apoptosis under heat stress","volume":"17","author":"Furusawa","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113933","article-title":"Palmatine induces G2\/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA","volume":"175","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0200","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3390\/cells11172734","article-title":"Apigetrin promotes TNF\u03b1-induced apoptosis, necroptosis, G2\/M phase cell cycle arrest, and ROS generation through inhibition of NF-\u03baB pathway in Hep3B liver cancer cells","volume":"11","author":"Bhosale","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114747","article-title":"Polo-like kinase 1 (PLK1) signaling in cancer and beyond","volume":"193","author":"Iliaki","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1747-1028-5-11","article-title":"An overview of Cdk1-controlled targets and processes","volume":"5","author":"Enserink","year":"2010","journal-title":"Cell Div"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0220","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0225","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0235","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000042","article-title":"Cancer and liver cirrhosis: implications on prognosis and management","volume":"1","author":"Pinter","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0245","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0255","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","article-title":"Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications","volume":"31","author":"Safri","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0260","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cld.2020.07.012","article-title":"Tyrosine kinase inhibitors and hepatocellular carcinoma","volume":"24","author":"da Fonseca","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00775-1","article-title":"Combination therapy for HCC: from CRISPR screening to the design of clinical therapies","volume":"6","author":"Wang","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0270","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/cancers13040669","article-title":"Drug combination in cancer treatment\u2014from cocktails to conjugated combinations","volume":"13","author":"Gilad","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-023-01509-2","article-title":"The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors","volume":"17","author":"Wei","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0280","series-title":"Drug Delivery to Tumors: Recent Strategies and Techniques","first-page":"89","article-title":"Combined therapy in cancer treatment","author":"Ma","year":"2025"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","article-title":"The biology of hepatocellular carcinoma: implications for genomic and immune therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbpa.2016.08.006","article-title":"How PEGylation influences protein conformational stability","volume":"34","author":"Lawrence","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0295","series-title":"Engineering of Biomaterials for Drug Delivery Systems","first-page":"363","article-title":"14 - PEGylation and its alternatives: a summary","author":"Abbina","year":"2018"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125957","article-title":"End-on PEGylation of heparin: effect on anticoagulant activity and complexation with protamine","volume":"249","author":"Amaral","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"2020","key":"10.1016\/j.ijbiomac.2025.145283_bb0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mco2.16","article-title":"Mitochondria as a target in cancer treatment","volume":"1","author":"Liu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216223","article-title":"Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria","volume":"564","author":"Bai","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-61779-382-0_12","article-title":"Relation between mitochondrial membrane potential and ROS formation","volume":"810","author":"Suski","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0330","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2024.100030","article-title":"Cell cycle dysregulation in cancer","volume":"77","author":"Glaviano","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145283_bb0340","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/antiox14040437","article-title":"Immunomodulatory effects of Symplectoteuthis oualaniensis protamine and its PEG derivative on macrophages: involvement of PI3K\/Akt signaling, redox regulation, and cell cycle modulation","volume":"14","author":"Li","year":"2025","journal-title":"Antioxidants"}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2025.147336","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}},{"DOI":"10.1016\/j.ijbiomac.2025.145283","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}},{"DOI":"10.1016\/j.ijbiomac.2025.147336","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"record-id":"72278"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025058386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025058386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:20:48Z","timestamp":1760826048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025058386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":68,"alternative-id":["S0141813025058386"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145283","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/j.ijbiomac.2025.145283","asserted-by":"object"}],"erratum":[{"id-type":"doi","id":"10.1016\/j.ijbiomac.2025.147336","asserted-by":"object"}]},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: A novel PEGylated squid-derived protamine protein in combination with sorafenib effectively inhibits hepatocellular carcinoma growth","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145283"}}